瑞迪博士实验室

US · RDY #1451 按市值排名上市于 1970

13.07 +0.17 +1.32%

实时 - 追踪5344个代码 - 心跳于270秒前 · 2026-10-16 19:30

关于 Dr. Reddy's Laboratories

Dr. Reddy's Laboratories 有限公司. 从事 the manufacture and marketing of 制药产品. It 运营 through the following 部分: 全球 Generics, 制药服务 and Active Ingredients, and Others. The 全球 Generics 部分 refers to the 制造 and marketing of prescription and over-the-counter finished 制药产品 ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The 制药服务 and Active Ingredients 部分专注于制造 and marketing of active 制药 ingredients and intermediates, also known as API, which are the principal ingredients for finished 制药产品. The Others 部分包括 the 运营 of the 子公司 of the company. The company was 成立 by Kallam Anji Reddy on February 24, 1984 and is 总部位于 in Hyderabad, India.

成立时间: 1984
首席执行官: Mr. Erez Israeli
员工人数: 27,527
总部地址: Hyderabad, Telangana, India
财年结束日: 03-31
官方网站: drreddys.com

公司概况

交易所: US
股票代码: RDY
市值排名: #1451
上市日期: 1970-01-01
市值: 10.89B
流通市值: 7.84B
总股数: 832.99M
流通股数: 599.98M

行业与主题板块

Infectious Disease Cannabis & Hemp Drug Manufacturers - Specialty & Generic Fractional Shares JP

浏览全部行业与主题板块

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

瑞迪博士实验室

关于 Dr. Reddy's Laboratories

公司概况

行业与主题板块